APO Research
Talk to an analyst

APO RESEARCH · REPORT

EAAT2 Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global EAAT2 Antibody Industry Growth and Trends Forecast to 2032

19 December 2025100 pages

Choose your research edition.

Industry ResearchEAAT2 Antibody Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal EAAT2 Antibody Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal EAAT2 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EAAT2 Antibody Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal EAAT2 Antibody Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global EAAT2 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for EAAT2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for EAAT2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EAAT2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of EAAT2 Antibody include Merck, United States Biological, Boster Biological Technology, Proteintech, NSJ Bioreagents, LSBio, GeneTex, FineTest and FabGennix International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global EAAT2 Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The EAAT2 Antibody market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global EAAT2 Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to EAAT2 Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global EAAT2 Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

EAAT2 Antibody Market by Company

Merck

United States Biological

Boster Biological Technology

Proteintech

NSJ Bioreagents

LSBio

GeneTex

FineTest

FabGennix International

Creative Biolabs

Cell Signaling Technology

Bioss

Affinity Biosciences

Abcam

EAAT2 Antibody Segment by Type

Polyclonal

Monoclonal

EAAT2 Antibody Segment by Application

Enzyme Linked Immunosorbent Assay

Immunoprecipitation

Immunocytochemistry

Others

EAAT2 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EAAT2 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EAAT2 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EAAT2 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of EAAT2 Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of EAAT2 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polyclonal Table 2. Major Company of Monoclonal Table 3. Global EAAT2 Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global EAAT2 Antibody Sales by Type (2021-2026) & (Kg) Table 5. Global EAAT2 Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global EAAT2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global EAAT2 Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global EAAT2 Antibody Price by Type (2021-2026) & (US$/Kg) Table 9. Global EAAT2 Antibody Sales by Type (2027-2032) & (Kg) Table 10. Global EAAT2 Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global EAAT2 Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global EAAT2 Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global EAAT2 Antibody Price by Type (2027-2032) & (US$/Kg) Table 14. North America EAAT2 Antibody Sales by Type (2021-2026) & (Kg) Table 15. North America EAAT2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe EAAT2 Antibody Sales by Type (2021-2026) & (Kg) Table 17. Europe EAAT2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific EAAT2 Antibody Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific EAAT2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America EAAT2 Antibody Sales by Type (2021-2026) & (Kg) Table 21. Latin America EAAT2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa EAAT2 Antibody Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa EAAT2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. EAAT2 Antibody Industry Trends Table 25. EAAT2 Antibody Industry Drivers Table 26. EAAT2 Antibody Industry Opportunities and Challenges Table 27. EAAT2 Antibody Industry Restraints Table 28. Global EAAT2 Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global EAAT2 Antibody Revenue Market Share by Company (2021-2026) Table 30. Global EAAT2 Antibody Sales by Company (2021-2026) & (Kg) Table 31. Global EAAT2 Antibody Sales Share by Company (2021-2026) Table 32. Global EAAT2 Antibody Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global EAAT2 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global EAAT2 Antibody Major Company Production Sites and Headquarters Table 35. Global EAAT2 Antibody Company, Product Type & Application Table 36. Global EAAT2 Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global EAAT2 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global EAAT2 Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global EAAT2 Antibody Sales by Region (2021-2026) & (Kg) Table 41. Global EAAT2 Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global EAAT2 Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global EAAT2 Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global EAAT2 Antibody Sales by Region (2027-2032) & (Kg) Table 46. Global EAAT2 Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global EAAT2 Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global EAAT2 Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global EAAT2 Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global EAAT2 Antibody Sales by Application (2021-2026) & (Kg) Table 52. Global EAAT2 Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global EAAT2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global EAAT2 Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global EAAT2 Antibody Price by Application (2021-2026) & (US$/Kg) Table 56. Global EAAT2 Antibody Sales by Application (2027-2032) & (Kg) Table 57. Global EAAT2 Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global EAAT2 Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global EAAT2 Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global EAAT2 Antibody Price by Application (2027-2032) & (US$/Kg) Table 61. North America EAAT2 Antibody Sales by Application (2021-2026) & (Kg) Table 62. North America EAAT2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe EAAT2 Antibody Sales by Application (2021-2026) & (Kg) Table 64. Europe EAAT2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific EAAT2 Antibody Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific EAAT2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America EAAT2 Antibody Sales by Application (2021-2026) & (Kg) Table 68. Latin America EAAT2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa EAAT2 Antibody Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa EAAT2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Merck EAAT2 Antibody Product Portfolio Table 75. Merck Recent Development Table 76. United States Biological Company Information Table 77. United States Biological Business Overview Table 78. United States Biological EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. United States Biological EAAT2 Antibody Product Portfolio Table 80. United States Biological Recent Development Table 81. Boster Biological Technology Company Information Table 82. Boster Biological Technology Business Overview Table 83. Boster Biological Technology EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Boster Biological Technology EAAT2 Antibody Product Portfolio Table 85. Boster Biological Technology Recent Development Table 86. Proteintech Company Information Table 87. Proteintech Business Overview Table 88. Proteintech EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Proteintech EAAT2 Antibody Product Portfolio Table 90. Proteintech Recent Development Table 91. NSJ Bioreagents Company Information Table 92. NSJ Bioreagents Business Overview Table 93. NSJ Bioreagents EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. NSJ Bioreagents EAAT2 Antibody Product Portfolio Table 95. NSJ Bioreagents Recent Development Table 96. LSBio Company Information Table 97. LSBio Business Overview Table 98. LSBio EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. LSBio EAAT2 Antibody Product Portfolio Table 100. LSBio Recent Development Table 101. GeneTex Company Information Table 102. GeneTex Business Overview Table 103. GeneTex EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. GeneTex EAAT2 Antibody Product Portfolio Table 105. GeneTex Recent Development Table 106. FineTest Company Information Table 107. FineTest Business Overview Table 108. FineTest EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. FineTest EAAT2 Antibody Product Portfolio Table 110. FineTest Recent Development Table 111. FabGennix International Company Information Table 112. FabGennix International Business Overview Table 113. FabGennix International EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. FabGennix International EAAT2 Antibody Product Portfolio Table 115. FabGennix International Recent Development Table 116. Creative Biolabs Company Information Table 117. Creative Biolabs Business Overview Table 118. Creative Biolabs EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. Creative Biolabs EAAT2 Antibody Product Portfolio Table 120. Creative Biolabs Recent Development Table 121. Cell Signaling Technology Company Information Table 122. Cell Signaling Technology Business Overview Table 123. Cell Signaling Technology EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Cell Signaling Technology EAAT2 Antibody Product Portfolio Table 125. Cell Signaling Technology Recent Development Table 126. Bioss Company Information Table 127. Bioss Business Overview Table 128. Bioss EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 129. Bioss EAAT2 Antibody Product Portfolio Table 130. Bioss Recent Development Table 131. Affinity Biosciences Company Information Table 132. Affinity Biosciences Business Overview Table 133. Affinity Biosciences EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 134. Affinity Biosciences EAAT2 Antibody Product Portfolio Table 135. Affinity Biosciences Recent Development Table 136. Abcam Company Information Table 137. Abcam Business Overview Table 138. Abcam EAAT2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 139. Abcam EAAT2 Antibody Product Portfolio Table 140. Abcam Recent Development Table 141. North America EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 142. North America EAAT2 Antibody Sales by Country (2021-2026) & (Kg) Table 143. North America EAAT2 Antibody Sales Market Share by Country (2021-2026) Table 144. North America EAAT2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 145. North America EAAT2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 146. North America EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America EAAT2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 148. North America EAAT2 Antibody Market Share by Country (2021-2026) Table 149. North America EAAT2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America EAAT2 Antibody Market Share Forecast by Country (2027-2032) Table 151. Europe EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 152. Europe EAAT2 Antibody Sales by Country (2021-2026) & (Kg) Table 153. Europe EAAT2 Antibody Sales Market Share by Country (2021-2026) Table 154. Europe EAAT2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 155. Europe EAAT2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 156. Europe EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe EAAT2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe EAAT2 Antibody Market Share by Country (2021-2026) Table 159. Europe EAAT2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe EAAT2 Antibody Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific EAAT2 Antibody Sales by Country (2021-2026) & (Kg) Table 163. Asia-Pacific EAAT2 Antibody Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific EAAT2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 165. Asia-Pacific EAAT2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific EAAT2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific EAAT2 Antibody Market Share by Country (2021-2026) Table 169. Asia-Pacific EAAT2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific EAAT2 Antibody Market Share Forecast by Country (2027-2032) Table 171. Latin America EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 172. Latin America EAAT2 Antibody Sales by Country (2021-2026) & (Kg) Table 173. Latin America EAAT2 Antibody Sales Market Share by Country (2021-2026) Table 174. Latin America EAAT2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 175. Latin America EAAT2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America EAAT2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America EAAT2 Antibody Market Share by Country (2021-2026) Table 179. Latin America EAAT2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America EAAT2 Antibody Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa EAAT2 Antibody Sales by Country (2021-2026) & (Kg) Table 183. Middle East and Africa EAAT2 Antibody Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa EAAT2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 185. Middle East and Africa EAAT2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa EAAT2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa EAAT2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa EAAT2 Antibody Market Share by Country (2021-2026) Table 189. Middle East and Africa EAAT2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa EAAT2 Antibody Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. EAAT2 Antibody Distributors List Table 194. EAAT2 Antibody Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. EAAT2 Antibody Image Figure 2. Global EAAT2 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EAAT2 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global EAAT2 Antibody Sales (2021-2032) & (Kg) Figure 5. Polyclonal Image Figure 6. Global Polyclonal Sales YoY Growth (2021-2032) & (Kg) Figure 7. Monoclonal Image Figure 8. Global Monoclonal Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global EAAT2 Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global EAAT2 Antibody Market Share by Type 2025 VS 2032 Figure 11. North America EAAT2 Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America EAAT2 Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe EAAT2 Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe EAAT2 Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific EAAT2 Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific EAAT2 Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America EAAT2 Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America EAAT2 Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa EAAT2 Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa EAAT2 Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 EAAT2 Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Enzyme Linked Immunosorbent Assay Image Figure 24. Global Enzyme Linked Immunosorbent Assay Sales YoY Growth (2021-2032) & (Kg) Figure 25. Immunoprecipitation Image Figure 26. Global Immunoprecipitation Sales YoY Growth (2021-2032) & (Kg) Figure 27. Immunocytochemistry Image Figure 28. Global Immunocytochemistry Sales YoY Growth (2021-2032) & (Kg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global EAAT2 Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global EAAT2 Antibody Market Share by Application 2025 VS 2032 Figure 33. North America EAAT2 Antibody Sales Market Share in Volume by Application in 2025 Figure 34. North America EAAT2 Antibody Sales Market Share in Value by Application in 2025 Figure 35. Europe EAAT2 Antibody Sales Market Share in Volume by Application in 2025 Figure 36. Europe EAAT2 Antibody Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific EAAT2 Antibody Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific EAAT2 Antibody Sales Market Share in Value by Application in 2025 Figure 39. Latin America EAAT2 Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Latin America EAAT2 Antibody Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa EAAT2 Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa EAAT2 Antibody Sales Market Share in Value by Application in 2025 Figure 43. North America EAAT2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America EAAT2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America EAAT2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America EAAT2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe EAAT2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe EAAT2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe EAAT2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe EAAT2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific EAAT2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific EAAT2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific EAAT2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific EAAT2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America EAAT2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America EAAT2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America EAAT2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America EAAT2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa EAAT2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa EAAT2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa EAAT2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa EAAT2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. EAAT2 Antibody Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. EAAT2 Antibody Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Enzyme Linked Immunosorbent Assay
  • Immunoprecipitation
  • Immunocytochemistry
  • Others
Companies covered
  • Merck
  • United States Biological
  • Boster Biological Technology
  • Proteintech
  • NSJ Bioreagents
  • LSBio
  • GeneTex
  • FineTest
  • FabGennix International
  • Creative Biolabs
  • Cell Signaling Technology
  • Bioss
  • Affinity Biosciences
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EAAT2 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global EAAT2 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 EAAT2 Antibody Market by Type
  6. 1.3.1 Polyclonal
  7. 1.3.2 Monoclonal
  8. 1.4 Global EAAT2 Antibody Market Size by Type
  9. 1.4.1 Global EAAT2 Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global EAAT2 Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global EAAT2 Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America EAAT2 Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe EAAT2 Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific EAAT2 Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America EAAT2 Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa EAAT2 Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 EAAT2 Antibody Industry Trends
  2. 2.2 EAAT2 Antibody Industry Drivers
  3. 2.3 EAAT2 Antibody Industry Opportunities and Challenges
  4. 2.4 EAAT2 Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by EAAT2 Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by EAAT2 Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by EAAT2 Antibody Price (2021-2026)
  4. 3.4 Global EAAT2 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global EAAT2 Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global EAAT2 Antibody Company, Product Type & Application
  7. 3.7 Global EAAT2 Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global EAAT2 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 EAAT2 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 EAAT2 Antibody Tier 1, Tier 2, and Tier 3
4 EAAT2 Antibody Regional Status and Outlook
  1. 4.1 Global EAAT2 Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global EAAT2 Antibody Historic Market Size by Region
  3. 4.2.1 Global EAAT2 Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global EAAT2 Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global EAAT2 Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global EAAT2 Antibody Forecasted Market Size by Region
  7. 4.3.1 Global EAAT2 Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global EAAT2 Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global EAAT2 Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 EAAT2 Antibody by Application
  1. 5.1 EAAT2 Antibody Market by Application
  2. 5.1.1 Enzyme Linked Immunosorbent Assay
  3. 5.1.2 Immunoprecipitation
  4. 5.1.3 Immunocytochemistry
  5. 5.1.4 Others
  6. 5.2 Global EAAT2 Antibody Market Size by Application
  7. 5.2.1 Global EAAT2 Antibody Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global EAAT2 Antibody Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global EAAT2 Antibody Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America EAAT2 Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe EAAT2 Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific EAAT2 Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America EAAT2 Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa EAAT2 Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck EAAT2 Antibody Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 United States Biological
  8. 6.2.1 United States Biological Company Information
  9. 6.2.2 United States Biological Business Overview
  10. 6.2.3 United States Biological EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 United States Biological EAAT2 Antibody Product Portfolio
  12. 6.2.5 United States Biological Recent Developments
  13. 6.3 Boster Biological Technology
  14. 6.3.1 Boster Biological Technology Company Information
  15. 6.3.2 Boster Biological Technology Business Overview
  16. 6.3.3 Boster Biological Technology EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boster Biological Technology EAAT2 Antibody Product Portfolio
  18. 6.3.5 Boster Biological Technology Recent Developments
  19. 6.4 Proteintech
  20. 6.4.1 Proteintech Company Information
  21. 6.4.2 Proteintech Business Overview
  22. 6.4.3 Proteintech EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Proteintech EAAT2 Antibody Product Portfolio
  24. 6.4.5 Proteintech Recent Developments
  25. 6.5 NSJ Bioreagents
  26. 6.5.1 NSJ Bioreagents Company Information
  27. 6.5.2 NSJ Bioreagents Business Overview
  28. 6.5.3 NSJ Bioreagents EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NSJ Bioreagents EAAT2 Antibody Product Portfolio
  30. 6.5.5 NSJ Bioreagents Recent Developments
  31. 6.6 LSBio
  32. 6.6.1 LSBio Company Information
  33. 6.6.2 LSBio Business Overview
  34. 6.6.3 LSBio EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 LSBio EAAT2 Antibody Product Portfolio
  36. 6.6.5 LSBio Recent Developments
  37. 6.7 GeneTex
  38. 6.7.1 GeneTex Company Information
  39. 6.7.2 GeneTex Business Overview
  40. 6.7.3 GeneTex EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GeneTex EAAT2 Antibody Product Portfolio
  42. 6.7.5 GeneTex Recent Developments
  43. 6.8 FineTest
  44. 6.8.1 FineTest Company Information
  45. 6.8.2 FineTest Business Overview
  46. 6.8.3 FineTest EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 FineTest EAAT2 Antibody Product Portfolio
  48. 6.8.5 FineTest Recent Developments
  49. 6.9 FabGennix International
  50. 6.9.1 FabGennix International Company Information
  51. 6.9.2 FabGennix International Business Overview
  52. 6.9.3 FabGennix International EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 FabGennix International EAAT2 Antibody Product Portfolio
  54. 6.9.5 FabGennix International Recent Developments
  55. 6.10 Creative Biolabs
  56. 6.10.1 Creative Biolabs Company Information
  57. 6.10.2 Creative Biolabs Business Overview
  58. 6.10.3 Creative Biolabs EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Creative Biolabs EAAT2 Antibody Product Portfolio
  60. 6.10.5 Creative Biolabs Recent Developments
  61. 6.11 Cell Signaling Technology
  62. 6.11.1 Cell Signaling Technology Company Information
  63. 6.11.2 Cell Signaling Technology Business Overview
  64. 6.11.3 Cell Signaling Technology EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cell Signaling Technology EAAT2 Antibody Product Portfolio
  66. 6.11.5 Cell Signaling Technology Recent Developments
  67. 6.12 Bioss
  68. 6.12.1 Bioss Company Information
  69. 6.12.2 Bioss Business Overview
  70. 6.12.3 Bioss EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bioss EAAT2 Antibody Product Portfolio
  72. 6.12.5 Bioss Recent Developments
  73. 6.13 Affinity Biosciences
  74. 6.13.1 Affinity Biosciences Company Information
  75. 6.13.2 Affinity Biosciences Business Overview
  76. 6.13.3 Affinity Biosciences EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Affinity Biosciences EAAT2 Antibody Product Portfolio
  78. 6.13.5 Affinity Biosciences Recent Developments
  79. 6.14 Abcam
  80. 6.14.1 Abcam Company Information
  81. 6.14.2 Abcam Business Overview
  82. 6.14.3 Abcam EAAT2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Abcam EAAT2 Antibody Product Portfolio
  84. 6.14.5 Abcam Recent Developments
7 North America by Country
  1. 7.1 North America EAAT2 Antibody Sales by Country
  2. 7.1.1 North America EAAT2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America EAAT2 Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America EAAT2 Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America EAAT2 Antibody Market Size by Country
  6. 7.2.1 North America EAAT2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America EAAT2 Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America EAAT2 Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe EAAT2 Antibody Sales by Country
  2. 8.1.1 Europe EAAT2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe EAAT2 Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe EAAT2 Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe EAAT2 Antibody Market Size by Country
  6. 8.2.1 Europe EAAT2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe EAAT2 Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe EAAT2 Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific EAAT2 Antibody Sales by Country
  2. 9.1.1 Asia-Pacific EAAT2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific EAAT2 Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific EAAT2 Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific EAAT2 Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific EAAT2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific EAAT2 Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific EAAT2 Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America EAAT2 Antibody Sales by Country
  2. 10.1.1 South America EAAT2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America EAAT2 Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America EAAT2 Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America EAAT2 Antibody Market Size by Country
  6. 10.2.1 South America EAAT2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America EAAT2 Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America EAAT2 Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa EAAT2 Antibody Sales by Country
  2. 11.1.1 Middle East and Africa EAAT2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa EAAT2 Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa EAAT2 Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa EAAT2 Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa EAAT2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa EAAT2 Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa EAAT2 Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 EAAT2 Antibody Value Chain Analysis
  2. 12.1.1 EAAT2 Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 EAAT2 Antibody Production Mode & Process
  7. 12.2 EAAT2 Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 EAAT2 Antibody Distributors
  10. 12.2.3 EAAT2 Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst